Advanced Guidance for Ocular Gene Therapy
Strategic, translational, and clinical insights for investors, startups, and academic groups
Our Expertise
Vector Design & Candidate Selection
Optimize AAV vector design and identify strong clinical candidates
IND-Enabling Studies & GLP Toxicology
Design IND-enabling studies, efficacy models, biodistribution, and GLP toxicology
Functional Potency Assay Design
Develop functional potency assays that support translatinal and regulatory readiness
How we support our clients
Investors
De-risk ocular gene therapy investments with scientific, regulatory, and CMC diligence
Startups
Build a credible path from preclinical to IND readiness
Academic Teams
Translate early science into a focused, development ready program
Why AAVizion
A unique blend of specialized ocular gene therapy expertise and long-standing ophthalmic drug discovery experience
Extensive Ocular Gene Therapy Expertise
Over two decades of experience in ocular gene therapy for inherited retinal conditions
Expert Vision
Broad Ocular Drug Discovery Expertise
Four decades of combined experience in ocular drug discovery spanning small molecules, biologics, and antibodies.
AAVision Methods
.jpg)
Eye-Centricity
Focused guidance tailored to ocular therapeutics and translational strategy, and development planning